NCT00890084View on ClinicalTrials.gov

Telmisartan Tab Hypertension

CompletedOBSERVATIONAL
Enrollment

2,913

Participants

Timeline

Start Date

April 30, 2009

Primary Completion Date

December 31, 2009

Conditions
Hypertension
Interventions
DRUG

Telmisartan or Telmisartan + Hydrochlorothiazide (HCTZ)

Telmisartan 40mg or 80mg +/- HCTZ 12.5mg or 25mg

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY